Immunotherapeutic Approaches Directed at MZB1 for Plasma Cell and B Cell Malignancies
Invention type: Technology
/
Case number: #26513J
Researchers
Jianzhu Chen
/
Mariateresa Fulciniti
/
Mehmet Samur
/
Elena Maroto Martin
/
Yingjie Zhao
/
Nikola Ivica
/
Mikhil Munshi
Departments: Department of Biology, David H Koch Institute for Integrative Cancer Res
Technology Areas: Biotechnology: Synthetic Biology / Drug Discovery and Research Tools: Genomics & Proteomics / Therapeutics: Cell Based Therapy, Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
antibodies targeting an hla-mzb1 peptide complex, pharmaceutical compositions comprising the same, and methods of use
United States of America | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.